Angiolab Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2015	FY 2014
Period Ending	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Net Income	-1,187	-350.31
Depreciation & Amortization	232.44	152.02
Asset Writedown & Restructuring Costs	526.96	-
Provision & Write-off of Bad Debts	-	16.3
Other Operating Activities	48.69	43.09
Change in Accounts Receivable	-2.57	-38.95
Change in Inventory	54.85	-49.79
Change in Accounts Payable	16.01	-
Change in Other Net Operating Assets	227.4	45.25
Operating Cash Flow	-82.73	-182.39
Capital Expenditures	-22.57	-
Sale (Purchase) of Intangibles	-70.04	-42.01
Investment in Securities	1,089	-2,823
Other Investing Activities	233.92	-323.42
Investing Cash Flow	1,231	-3,189
Long-Term Debt Issued	-	100
Long-Term Debt Repaid	-600	-
Net Debt Issued (Repaid)	-600	100
Issuance of Common Stock	-	2,993
Financing Cash Flow	-600	3,093
Miscellaneous Cash Flow Adjustments	-	0
Net Cash Flow	547.94	-277.86
Free Cash Flow	-105.3	-182.39
Free Cash Flow Margin	-14.99%	-20.76%
Free Cash Flow Per Share	-120.34	-208.26
Levered Free Cash Flow	-44.36	-
Unlevered Free Cash Flow	-43.78	-
Change in Working Capital	295.69	-43.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.